NI
ASMB icon

Numeric Investors’s Assembly Biosciences ASMB Stock Holding History

Numeric Investors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$557K Buy
+1,025
New +$464K ﹤0.01% 870
2014
Q1 		– Sell
-1,352
Closed -$310K – 778
2013
Q4 		$310K Buy
+1,352
New +$246K 0.01% 682

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Numeric Investors's ASMB Position: Q4 2017 in Review

Numeric Investors opened a new position in Assembly Biosciences (ASMB) in Q4 2017: 1,025 shares worth $557K. The stake represents ﹤0.01% of the portfolio and ranks #870 among its holdings. This is a return to the name: Numeric Investors previously reported a position in ASMB as recently as Q4 2013.

Numeric Investors first reported a position in ASMB in Q4 2013 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold ASMB as of Q4 2017.

  • Numeric Investors held 1,025 shares of Assembly Biosciences worth $557K as of Q4 2017.
  • Assembly Biosciences was a new Numeric Investors position in Q4 2017.
  • Assembly Biosciences made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #870 holding.
  • Numeric Investors first reported a position in Assembly Biosciences in Q4 2013 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.